LZTR1 Antikörper (N-Term)
Kurzübersicht für LZTR1 Antikörper (N-Term) (ABIN500210)
Target
Alle LZTR1 Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Bindungsspezifität
- N-Term
-
Kreuzreaktivität (Details)
- Species reactivity (tested):Human, mouse, rat
-
Aufreinigung
- Peptide affinity chromatography
-
Immunogen
- LZTR1 antibody was raised against a 14 amino acid peptide near the amino terminus of human LZTR1.
-
Isotyp
- IgG
-
-
-
-
Applikationshinweise
-
ELISA. Western blot: 1 - 2 μg/mL. Immunohistochemistry on paraffin sections.
Other applications not tested.
Optimal dilutions are dependent on conditions and should be determined by the user. -
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Konzentration
- 1.0 mg/mL
-
Buffer
- PBS containing 0.02 % sodium azide
-
Konservierungsmittel
- Sodium azide
-
Vorsichtsmaßnahmen
- This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Handhabung
- Avoid repeated freezing and thawing.
-
Lagerung
- -20 °C
-
Informationen zur Lagerung
- Store the antibody (in aliquots) at -20 °C.
-
-
- LZTR1 (Leucine-Zipper-Like Transcription Regulator 1 (LZTR1))
-
Andere Bezeichnung
- LZTR1
-
Hintergrund
- LZTR1, a member of the BTB-kelch superfamily, was initially described as a putative transcriptional regulator based on weak homology to members of the basic leucine zipper-like family, the encoded protein subsequently has been shown to localize exclusively to the Golgi network where it may help stabilize the Golgi complex. Deletion of this gene may be associated with DiGeorge syndrome, a developmental field defect involving the third and fourth pharyngeal pouches, causing the absence of thymus and parathyroid glands, congenital cardiac abnormalities and facial dysmorphism. LZTR1 is tyrosine phosphorylated and subsequently degraded upon induction of apoptosis.Synonyms: Leucine zipper-like transcription regulator 1
-
Gen-ID
- 8216
-
UniProt
- Q20WK0
Target
-